We write to raise concerns about the recent paper by Chapman et al on single maintenance and reliever therapy (SMART) of asthma, 1 on the basis that it misrepresents published scientific evidence. The errors include:
1. Reporting outcome measures for one treatment arm from several doubleblind studies (table 1 4 with juxtaposition of text to imply that its conclusions were relevant to the studies described immediately before, and failure to cite a more relevant Cochrane review. 5 
Criticism of peer-reviewed publications
on the basis of the use of outcome measures which were standard for other randomised controlled trials in asthma at the time (eg, criteria for exacerbations), or on the basis of omission of outcome measures which were either not available (eg, the adherence device used in a 1994 publication) or which have already been reported in a peer-reviewed publication (eg, a composite measure of asthma control 2 ).
Misrepresentation of scientific evidence, whether in a data paper or a review, damages the scientific credibility of a journal. It is difficult to understand how the above errors could have passed through the usually rigorous Thorax peer review system, and this should be a matter of concern to the Editorial Board. The errors in the article, given their number and nature, cannot be addressed by simply publishing an erratum. We call on Thorax to respond appropriately. 
